Pressmeddelanden från Brain+

Invitation to Investor Webinar on Monday 25th of November at 15:30: Update on commercial status and new opportunities

Copenhagen, Denmark, 21 November 2024 – Brain+ A/S (Nasdaq First North: BRAINP) Brain+ invites its shareholders as well as other investors ...

Cision • Igår 15:30

Brain+ closes new Danish municipality sales contract on Ayla – your CST Assistant

Copenhagen, Denmark, 1 November 2024 – Brain+ A/S (Nasdaq First North: BRAINP) Brain+ A/S (“Brain+” or “the Company”) has signed a new intr...

Cision • 01 Nov 11:57

Brain+ progresses UK commercial outreach and hosts the first of a series of webinars on the value of Cognitive Stimulation Therapy

Copenhagen, Denmark, 21 October 2024 – Brain+ A/S (Nasdaq First North: BRAINP) End September 2024, Brain+ A/S (“Brain+” or “the Company”) l...

Cision • 21 Oct 11:54

Brain+ unveils new visual brand and website to elevate its Ayla Dementia Care solutions

Copenhagen, Denmark, 11 October 2024 – Brain+ A/S (Nasdaq First North: BRAINP) Late September, Brain+ A/S (“Brain+” or “the Company”) revea...

Cision • 11 Oct 09:04

Brain+ announces first day of trading in new shares from the TO 4 warrant exercise and the related directed issue

Copenhagen, Denmark, 7 October 2024– Brain+ A/S (Nasdaq First North: BRAINP) On 1 October 2024, Brain+ A/S (“Brain+” or “the Company”) anno...

Cision • 07 Oct 11:50

Brain+ launches Ayla – your CST Assistant into the UK dementia market

Copenhagen, Denmark, 2 October 2024 – Brain+ A/S (Nasdaq First North: BRAINP) Brain+ A/S (“Brain+” or “the Company”) recently obtained cert...

Cision • 02 Oct 10:32

Brain+ announces the outcome of its series TO 4 warrant exercise and the decision to carry out a directed share issue to cover guarantor subscriptions

COMPANY ANNOUNCEMENT Copenhagen, Denmark, 1 October 2024– Brain+ A/S (Nasdaq First North: BRAINP) Brain+ A/S (“Brain+” or “the Company”) a...

Cision • 01 Oct 12:11

Ayla – your CST Assistant has been registered in the UK as a certified Medical Device Software for dementia therapy

Copenhagen, Denmark, 1 October 2024 – Brain+ A/S (Nasdaq First North: BRAINP) Brain+ A/S (“Brain+” or “the Company”) informs that Ayla – yo...

Cision • 01 Oct 09:23

Brain+ confirms imminent commercial launch of Ayla – your CST Assistant as a medical device in the UK

Copenhagen, Denmark, 25 September 2024 – Brain+ A/S (Nasdaq First North: BRAINP) Summary: Brain+ A/S (“Brain+” or the “Company”) has to da...

Cision • 25 Sep 10:43

Brain+ informs of three product releases planned for 2025 and introduces a platform renaming as part of its UK commercialization

Copenhagen, Denmark, 23 September 2024 – Brain+ A/S (Nasdaq First North: BRAINP) Brain+ A/S (“Brain+” or the “Company”) unveils new product...

Cision • 23 Sep 12:15

Brain+ A/S announces additional commitments of DKK 1.4 million in the ongoing TO 4 warrant exercise, which is now covered at 40.4%

Copenhagen, Denmark, 20 September 2024 – Brain+ A/S (Nasdaq First North: BRAINP) Brain+ A/S (“Brain+” or “the Company”) has received additi...

Cision • 20 Sep 08:43

Brain+ A/S announces that its board and management provide commitments to cover 13.7% of the warrants of series TO 4

Copenhagen, Denmark, 17 September 2024 – Brain+ A/S (Nasdaq First North: BRAINP) Brain+ A/S (“Brain+” or “the Company”) announces that memb...

Cision • 17 Sep 10:46

Brain+ is set to deliver on an ambitious UK commercial plan to reach recurring revenue of DKK 7-8 million by 2025 and DKK 25-27 million by 2027

Copenhagen, Denmark, 13 September 2024 - Brain+ A/S (Nasdaq First North: BRAINP) Summary: Brain+ is preparing for UK market release of its ...

Cision • 13 Sep 10:33

Brain+ A/S announces the exercise price for its warrants of series TO 4

Copenhagen, Denmark, 13 September 2024 – Brain+ A/S (Nasdaq First North: BRAINP) · The exercise price of the warrants of series TO 4 has ...

Cision • 13 Sep 09:08

First patient enrolled in a clinical trial to evaluate Brain+’ next generation cognitive training technology for Mild Cognitive Impairment

Copenhagen, Denmark, 5 September 2024 – Brain+ A/S (Nasdaq First North: BRAINP) In collaboration with Aalborg University Hospital, Brain+ h...

Cision • 05 Sep 09:30

Results from UK study of the CST-Assistant show clinical relevance, cost-benefit and product-market fit

Copenhagen, Denmark, 3 September 2024– Brain+ A/S (Nasdaq First North: BRAINP) A UK usability study of the CST-Assistant has been conducted...

Cision • 03 Sep 08:30

Invitation to Investor Webinar on Tues 3 Sept 2024 at 16:00 CEST: H1 2024 report and new Chief Commercial Officer

Copenhagen, Denmark, 30. August 2024 – Brain+ A/S (Nasdaq First North: BRAINP) Sign-up here (https://app.

Cision • 30 Aug 12:35

H1 2024: Brain+ has executed successfully in accordance with its UK-focused commercial strategy towards proof-of-business and realized financial results as expected

COMPANY ANNOUNCEMENT Copenhagen, Denmark, 29 August 2024 – Brain+ A/S (Nasdaq First North: BRAINP) Brain+ will host an investor webinar ...

Cision • 29 Aug 19:08

The CER of the CST-Assistant validated for UK regulatory compliance, documenting the product’s clinical performance

Copenhagen, Denmark, 27 August 2024 – Brain+ A/S (Nasdaq First North: BRAINP) · The Clinical Evaluation Report (CER) documents the safety...

Cision • 27 Aug 12:30

Brain+ fully on track towards market entry and first sales in the United Kingdom in H2 2024

NEWS RELEASE Copenhagen, Denmark, 23 August 2024 – Brain+ A/S (Nasdaq First North: BRAINP) · Brain+ is executing in full alignment with...

Cision • 23 Aug 08:50

New UK Labour government will focus on healthtech and dementia treatment as part of UK healthcare reform

Copenhagen, Denmark, 12 July 2024 – Brain+ A/S (Nasdaq First North: BRAINP) · Building a National Health Service (NHS) fit for the future...

Cision • 12 Jul 10:31

The CST Assistant v2.0 for Cognitive Stimulation Therapy (CST) now released in Denmark

Copenhagen, Denmark, 9 July 2024 – Brain+ A/S (Nasdaq First North: BRAINP) · The new version of the CST Assistant software solution offer...

Cision • 09 Jul 10:18

Directed issue of units to guarantors and registration of shares from both the rights issue and the directed issue

Copenhagen, Denmark, 5 July 2024 – Brain+ A/S (Nasdaq First North: BRAINP) · The Board of Directors in Brain+ has carried out a directed...

Cision • 05 Jul 13:34

Brain+ hires UK health tech rising star as Chief Commercial Officer

Copenhagen, Denmark, 28 June 2024 – Brain+ A/S (Nasdaq First North: BRAINP) · Devika Rani Wood has been appointed as Chief Commercial Off...

Cision • 28 Jun 10:00

Brain+ A/S publishes the outcome of its rights issue of units

Copenhagen, Denmark, June 27 2024 – Brain+ A/S (Nasdaq First North: BRAINP) NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIR...

Cision • 27 Jun 10:08

Brain+ obtains additional guarantee commitment in its ongoing rights issue

Copenhagen, Denmark, 24 June 2024 – Brain+ A/S (Nasdaq First North: BRAINP) Brain+ A/S (“Brain+” or the “Company”) announces that the Compa...

Cision • 24 Jun 10:06

Last day for subscription in the ongoing rights issue

Copenhagen, Denmark, 21 June, 2024 – Brain+ A/S (Nasdaq First North: BRAINP) NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDI...

Cision • 21 Jun 08:45

Correction - Brain+ receives guarantee commitment from health tech specialized German investment boutique and additional subscription from management in its ongoing rights issue

The company announcement made by Brain+ A/S at 12:37 today contained an inadvertent error in that the DKK 150,000 subscription from manageme...

Cision • 20 Jun 13:50

Brain+ receives guarantee commitment from health tech specialized German investment boutique and additional subscription from management in its ongoing rights issue

Copenhagen, Denmark, 20 June 2024 – Brain+ A/S (Nasdaq First North: BRAINP) This announcement constitutes inside information that Brain+ A/S...

Cision • 20 Jun 12:37

Brain+ establishes UK subsidiary

Copenhagen, Denmark, 17 June 2024 – Brain+ A/S (Nasdaq First North: BRAINP) · With the incorporation of Brian+ UK Limited, Brain+ has est...

Cision • 17 Jun 09:33

The CST-Assistant v2.0 is now ready for release in Denmark and on track for release in the UK end of Q3 2024

Copenhagen, Denmark, 14 June 2024 – Brain+ A/S (Nasdaq First North: BRAINP) · The development of all technical features and of high-quali...

Cision • 14 Jun 12:23

BioStock: Brain+ CEO - “CST is becoming the standard in dementia care”

Brain+ is a health tech company focused on treatment and management of dementia.

Cision • 13 Jun 08:46

BioStock Investor Pitch: Brain+

Brain+ is a health tech company focused on treatment and management of dementia.

Cision • 11 Jun 09:48

The subscription period in Brain+ unit rights issue begins today

Copenhagen, Denmark, 11 June 2024 – Brain+ A/S (Nasdaq First North: BRAINP) NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIR...

Cision • 11 Jun 08:47

Brain+ A/S informs of the last day of trading in its shares including preferential rights to subscribe in the upcoming unit rights issue

Copenhagen, Denmark, 4 June 2024 – Brain+ A/S (Nasdaq First North: BRAINP) NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRE...

Cision • 04 Jun 08:30

First steps taken to integrate CST-Assistant training with the formal CST-education in DK – a key market gateway milestone, also paving way for the UK

Copenhagen, Denmark, 3 June 2024 – Brain+ A/S (Nasdaq First North: BRAINP) · Under the CO-PI granted project, Brain+ has held the first ...

Cision • 03 Jun 11:51

Brain+ A/S: Publication of investment brochure

Copenhagen, Denmark, 31 May 2024 – Brain+ A/S (Nasdaq First North: BRAINP) The Board of Directors of Brain+ A/S (“Brain+” or the “Company”)...

Cision • 31 May 13:59

Brain+’ invites to online investor event with new Chairman

Copenhagen, Denmark, 24 May 2024 – Brain+ A/S (Nasdaq First North: BRAINP) · Monday, 27 May 2024 at 16:30 CEST, Brain+ hosts an investor...

Cision • 24 May 09:33

Minutes of Annual General Meeting in Brain+

Copenhagen, Denmark, May 22, 2024 – Brain+ A/S (Nasdaq First North: BRAINP) On 22 May 2024, at 8:00 AM (CEST) the Annual General Meeting of ...

Cision • 22 May 11:17

Brain+ informs of progress on its UK focused proof-of-business strategy plan

Copenhagen, Denmark, 16 May 2024 – Brain+ A/S (Nasdaq First North: BRAINP) · Supportive early user feedback from the ongoing AgeUK usabil...

Cision • 16 May 11:02

Brain+ A/S convenes the Annual General Meeting

Copenhagen, Denmark, April 28, 2023 – Brain+ A/S (Nasdaq First North: BRAINP) Notice is hereby given for the Annual General Meeting for 202...

Cision • 07 May 22:16

Brain+ publishes its Annual Report for 2023 – A year of market access, product development and a refocused commercial strategy

Copenhagen, Denmark, April 28, 2023 – Brain+ A/S (Nasdaq First North: BRAINP) Brain+ A/S (“Brain+”), a company pioneering health tech solu...

Cision • 07 May 13:03

Brain+ A/S announce a partially secured rights issue of units of approximately DKK 8.94 million to fund operations and execution of its UK commercialization plan

Copenhagen, Denmark, 7 May 2024 – Brain+ A/S (Nasdaq First North: BRAINP) This announcement constitutes inside information that Brain+ A/S...

Cision • 07 May 08:52

Brain+ updates on implementation and scaling activities for its CST-Assistant in Denmark

Copenhagen, Denmark, May 2, 2024 – Brain+ A/S (Nasdaq First North: BRAINP)  · Upcoming v2.

Cision • 02 May 08:30

Brain+’ CST-Assistant cited in leading Nordic Life Science magazine as an impactful health tech intervention for managing dementia

Copenhagen, Denmark, 30 April 2024 – Brain+ A/S (Nasdaq First North: BRAINP)  · Health tech, A.

Cision • 30 Apr 13:48

Brain+ releases preliminary annual financial statements for 2023

Copenhagen, Denmark, 30 April 2024 – Brain+ A/S (Nasdaq First North: BRAINP) · Brain+’ preliminary financial results for 2023 shows a gr...

Cision • 30 Apr 11:51

Brain+ announces a change in its Financial Calendar for 2024

Copenhagen, Denmark, April 29, 2024 – Brain+ A/S (Nasdaq First North: BRAINP) · Brain+ will publish its Annual Report for 2023 on May 7,...

Cision • 29 Apr 09:45

Successful educational CST course held with Malteser Germany based on the CST-Assistant

Copenhagen, Denmark, 26 April 2024 – Brain+ A/S (Nasdaq First North: BRAINP) · The value of the CST-Assistant v1.

Cision • 26 Apr 08:49

Brain+ announces registration of directed issue with the Danish Business Authority

Copenhagen, Denmark, April 10, 2024 – Brain+ A/S (Nasdaq First North: BRAINP) · New shares from the directed issue to guarantors of the s...

Cision • 11 Apr 10:08

Brain+ announces registration of series TO 3 warrant exercise with the Danish Business Authority

COMPANY ANNOUNCEMENT · New shares from the exercise of Brain+ warrants of series TO 3 have been registered with the Danish Business Autho...

Cision • 10 Apr 11:03

Brain+ announces the outcome of its series TO 3 warrant exercise and decision to carry out a directed share issue to cover guarantor commitments

Copenhagen, Denmark, March 26, 2024– Brain+ A/S (Nasdaq First North: BRAINP) · 91% of the warrants of series TO 3 have been subscribed fo...

Cision • 26 Mar 16:31

Brain+ A/S specifies how to get TO 3 warrant compensation

Copenhagen, Denmark, March 26, 2024 – Brain+ A/S (Nasdaq First North: BRAINP) · As announced on March 7, 2024, compensation is offered to...

Cision • 26 Mar 09:20

Brain+ A/S announces last day of trading in its warrants of series TO 3

COMPANY ANNOUNCEMENT Copenhagen, Denmark, 20 March 2024 – Brain+ A/S (Nasdaq First North: BRAINP) · Today, 20 March 2024 is the last day...

Cision • 20 Mar 10:54

Brain+ starts UK Pilot Project on CST-Therapist Companion in partnership with Age UK

· An important step in the company’s UK focused strategy plan building towards commercial release of CST-Therapist Companion and first sa...

Cision • 19 Mar 08:30

Brain+ strategy update: Focus on the UK to reach proof-of-business and commercial scaling in 2024-2025

· The UK is assessed to be the most attractive and accessible market for Brain+’ digital dementia solutions, of which CST-Therapist Compa...

Cision • 18 Mar 10:06

Brain+ announces that 77% of its warrants of series TO 3 are now covered by commitments

Copenhagen, Denmark, 15 March 2024 – Brain+ A/S (Nasdaq First North: BRAINP) · Firm commitments of exercise and guarantees from managemen...

Cision • 15 Mar 11:07

Brain+ announces that 58% of its warrants of series TO 3 are covered by early commitments

COMPANY ANNOUNCEMENT · Members of management and board members/observers have committed to exercise all their TO 3 warrants and provide a...

Cision • 11 Mar 12:54

Brain+ A/S announces amended terms for upcoming TO 3 warrant exercise

Brain+ A/S (Nasdaq First North: BRAINP) - This announcement constitutes inside information that Brain+ is obliged to make public pursuant to...

Cision • 07 Mar 08:52

Brain+ nominates an international digital health industry expert and experienced investor profile as new chairman candidate

COMPANY ANNOUNCEMENT Brain+ A/S (Nasdaq First North: BRAINP) - This information is information that Brain+ A/S is obliged to publish in ac...

Cision • 12 Feb 08:30

Brain+ partners with Quiddity Health, the #1 UK digital healthcare market specialist, to prepare UK market entry for CST-Therapist Companion

· Quiddity Health has a strong track-record of helping innovative digital therapeutic companies successfully enter the UK healthcare mark...

Cision • 09 Feb 08:30

Brain+ signs two new Danish sales contracts on CST-Therapist Companion and updates on the product’s commercial potential

Investor News Copenhagen, Denmark, January 18, 2024 – Brain+ A/S (Nasdaq First North: BRAINP) · CST-Therapist Companion sales contract s...

Cision • 18 Jan 08:30

Brain+ announces a change in the Chief Financial Officer position

COMPANY ANNOUNCEMENT · Hanne Leth Hillman, who has served as interim CFO since 1 May 2023, will continue in the role as the company’s new...

Cision • 09 Jan 09:18

Brain+’s chairman to step down

Brain+ A/S (Nasdaq First North, Denmark: BRAINP) This information is information that Brain+ A/S is obliged to publish in accordance with t...

Cision • 14 Dec 2023 18:46

Brain+ gets public grant of DKK 3.5 million to scale the implementation of CST-Therapist Companion in Denmark

Brain+ A/S (Nasdaq First North, Denmark: BRAINP) This information is information that Brain+ A/S is obliged to publish in accordance with t...

Cision • 14 Dec 2023 13:25

Brain+ closes sales contract with Copenhagen municipality on CST-Therapist Companion to support dementia care and therapy

Investor News · The contract gives Copenhagen initial access to use CST-Therapist Companion in three dementia care facilities and has the...

Cision • 11 Dec 2023 08:30

Brain+ nominated to CO-PI grant of up to DKK 3.5 million to scale implementation of CST-Therapist Companion into dementia care in Denmark

· The grant nomination is a strong validation of the relevance and potential of CST-Therapist Companion to digitally support an effective...

Cision • 23 Nov 2023 15:37

Brain+ and VIA University College start usability study on CST-Therapist Companion in Denmark

INVESTOR NEWS · Therapists from 5 Danish municipalities will participate in the study and deliver Cognitive Stimulation Therapy (CST) to ...

Cision • 14 Nov 2023 08:30

Brain+ announces a change to its Board of Directors

· Effective from end of November 2023, Betül Susamis Unaran, member of the Board of Directors of Brain+, has resigned from her position...

Cision • 02 Nov 2023 16:47

Brain+ announces registration with the Danish Business Authority and first day of trading of new shares

· The Brain+ series TO 2 warrant exercise and directed share issue have been registered with the Danish Business Authority (Danish: Erhve...

Cision • 24 Oct 2023 14:40

Brain+ announces the outcome of its series TO 2 warrant exercise and decision to carry out a directed share issue to cover guarantor commitments

COMPANY ANNOUNCEMENT · Brain+ announces that 74.

Cision • 18 Oct 2023 09:53

Brain+ presents its unique digital CST offerings at two key European dementia conferences in October

· At the 33[rd] Alzheimer’s Europe conference, Brain+ shares insight and initial data from its recent work to validate tailored content f...

Cision • 16 Oct 2023 13:37

Brain+ announces additional commitments in the ongoing exercise of warrants of series TO 2 to reach now a coverage of almost 50%

· Brain+ has received additional new commitments from existing shareholders to exercise approximately 3.

Cision • 12 Oct 2023 14:55

Commercial outlook and potential impact of grants and partnering activities

Copenhagen, Denmark, 12 October 2023 – Brain+ A/S (Nasdaq First North: BRAINP) · The 4th quarter of the year is “buying season” for Danis...

Cision • 12 Oct 2023 08:45

Brain+ A/S announces last day of trading in warrants of series TO 2

Copenhagen, Denmark, 12 October 2023 – Brain+ A/S (Nasdaq First North: BRAINP) · Today, 12 October is the last day of trading in the warr...

Cision • 12 Oct 2023 08:30

Minutes of the Extraordinary General Meeting

Copenhagen, Denmark, October 11, 2023 – Brain+ A/S (Nasdaq First North: BRAINP)

Cision • 11 Oct 2023 13:21

Copenhagen municipality sees potential in Brain+’ CST-Therapist Companion to deliver Cognitive Stimulation Therapy (CST) in the municipality’s nursing homes

Copenhagen, Denmark, October 11, 2023 - Brain+ A/S (Nasdaq First North: BRAINP) · Copenhagen is also one of the Danish municipalities wit...

Cision • 11 Oct 2023 08:37

Experienced life science profile and largest investor joins the Brain+ team as Strategic Partnerships Advisor to accelerate pharma partner deals

Experienced life science profile and largest investor joins the Brain+ team as Strategic Partnerships Advisor to accelerate pharma partner d...

Cision • 10 Oct 2023 14:00

Brain+ announces commitments from its largest shareholders in the ongoing exercise of warrants of series TO 2

COMPANY ANNOUNCEMENT Copenhagen, Denmark, 10 October 2023 – Brain+ A/S (Nasdaq First North: BRAINP) · Large Brain+ shareholders have com...

Cision • 10 Oct 2023 08:30

Brain+ releases new version of its CST-Therapist Companion dementia product with updated user features

Copenhagen, Denmark, 4 October 2023 – Brain+ A/S (Nasdaq First North: BRAINP) · A version 1.

Cision • 04 Oct 2023 08:30

Members of Brain+’ board and management commit to exercise all their warrants of series TO 2

COMPANY ANNOUNCEMENT Copenhagen, Denmark, 2 October 2023 – Brain+ A/S (Nasdaq First North: BRAINP) NOT FOR RELEASE, DISTRIBUTION OR PUBLIC...

Cision • 02 Oct 2023 08:30

Brain+ A/S announces the exercise price for its warrants of series TO 2

COMPANY ANNOUNCEMENT Copenhagen, Denmark, September 29, 2023 – Brain+ A/S (Nasdaq First North: BRAINP) NOT FOR RELEASE, DISTRIBUTION OR P...

Cision • 29 Sep 2023 08:30

Brain+ has convened an EGM to add a strong digital health industry profile to its board of directors

Tuesday, September 26, 2023, 8:45 CET – Brain+ A/S (Nasdaq First North: BRAINP) · Anish Shindore, a global digital health industry heavyw...

Cision • 26 Sep 2023 08:45

Notice of Extraordinary General Meeting

Cision • 26 Sep 2023 08:30

Brain+ online investor meeting: Status update, warrant exercise and Q&A

Copenhagen, Denmark, September 22, 2023 – Brain+ A/S (Nasdaq First North: BRAINP)

Cision • 22 Sep 2023 08:30

Brain+ awarded an EUopSTART grant by the Danish Innovation Fund to support 2[nd] stage of its EIC Accelerator application

Copenhagen, Denmark, September 20, 2023 – Brain+ A/S (Nasdaq First North: BRAINP) · The EUopSTART grant of up to DKK 50,000 will fund the...

Cision • 20 Sep 2023 08:30

Brain+ to present at DTx East 2023, a global summit for the digital therapeutics’ community, held in Boston, US on 26-28 September

Copenhagen, Denmark, September 13, 2023 – Brain+ A/S (Nasdaq First North: BRAINP) · Brain+ founder and CEO, Kim Baden-Kristensen has been...

Cision • 15 Sep 2023 08:30

Two Brain+ grant applications pass first evaluation gate with unanimous support from evaluators

Copenhagen, Denmark, September 13, 2023 – Brain+ A/S (Nasdaq First North: BRAINP) · The EIC Accelerator application of DKK 60 million in ...

Cision • 13 Sep 2023 08:30

Brain+ secures intellectual property rights for CST-Therapist Companion in the EU and the United Kingdom

Copenhagen, Denmark, September 8, 2023 – Brain+ A/S (Nasdaq First North: BRAINP) · Key design and user interface elements of CST-Therapis...

Cision • 08 Sep 2023 08:30

Summary of H1 2023 report: Brain+ has closed new sales contracts, built key customer engagement, developed a new product concept, achieved technology validations and secured new funding

Brain+ A/S (BRAINP) - Company Announcement Thursday, August 31, 2022, 8:30 CET Today, Brain+ has released its financial report for the peri...

Cision • 31 Aug 2023 08:30

Brain+ has submitted new public grant applications to raise up to DKK 67 million to develop and scale its digital dementia products

Copenhagen, Denmark, August 25, 2023 – Brain+ A/S (Nasdaq First North: BRAINP) · Dementia is a field of substantial unmet needs and high ...

Cision • 25 Aug 2023 08:30

Brain+ Online Investor Update

Copenhagen, Denmark, May 22, 2023 – Brain+ A/S (Nasdaq First North: BRAINP)

Cision • 22 Aug 2023 08:30

Brain+ and Danish municipalities are advancing the development of version 2.0 of the CST-Therapist Companion

Copenhagen, Denmark, August 9, 2023 – Brain+ A/S (Nasdaq First North: BRAINP) · Since the introduction of CST-Therapist Companion v1.

Cision • 09 Aug 2023 08:30

Breakthrough Alzheimer’s drug approval seen to renew dementia drug investments and increase the potential for digital dementia therapies – good news for Brain+

Copenhagen, Denmark, July 10, 2023 – Brain+ A/S (Nasdaq First North: BRAINP) · The US FDA has granted full approval to Lecanemab, the fir...

Cision • 10 Jul 2023 08:50

Brain+ presents at the 5[th] Annual DTx (Digital Therapeutics) Europe conference

Copenhagen, Denmark, June 27, 2023 – Brain+ A/S (Nasdaq First North: BRAINP) Brain+ A/S (“BRAINP”) today informed that the company has been...

Cision • 27 Jun 2023 08:30

Brain+ A/S carries out a directed issue as compensation to guarantors of its unit rights issue

COMPANY ANNOUNCEMENT Copenhagen, Denmark, June 12, 2023 – Brain+ A/S (Nasdaq First North: BRAINP) NOT FOR RELEASE, DISTRIBUTION OR PUBLICA...

Cision • 12 Jun 2023 09:15

Brain+ A/S announces the first day of trading for the new shares and warrants from its rights issue

COMPANY ANNOUNCEMENT Copenhagen, Denmark, June 9, 2023 – Brain+ A/S (Nasdaq First North: BRAINP) NOT FOR RELEASE, DISTRIBUTION OR PUBLICAT...

Cision • 09 Jun 2023 08:36

Brain+ A/S announces a delay of the first day of trading for the new shares from its rights issue

Cision • 06 Jun 2023 16:29

Brain+ A/S published the outcome of its rights issue of units

COMPANY ANNOUNCEMENT Copenhagen, Denmark, May 30, 2023 – Brain+ A/S (Nasdaq First North: BRAINP) NOT FOR RELEASE, DISTRIBUTION OR PUBLICAT...

Cision • 30 May 2023 14:52

Minutes of the Annual General Meeting 2023 in Brain+ A/S

On Friday 26[th] of May at 08:00 CET, Brain+ A/S held its Annual General Meeting.

Cision • 26 May 2023 09:30

Brain+ showcased at Danish Dementia Days and at Altenpflege in Germany, Europe’s largest elderly care conference

Copenhagen, Denmark, May 23, 2023 – Brain+ A/S (Nasdaq First North: BRAINP) · Brain+ was featured at The Dementia Days in Copenhagen, the...

Cision • 23 May 2023 09:00

Börskollen

För dig med koll på börsen